In the last three years I have been working in development or preparation of radiopharmaceuticals including radiolabelling of monoclonal antibodies (in form of whole and fragmented antibodies of nimotuzumab and trastuzumab) and peptide with Lu-177, radiolabelling of rituximab with I-131.
Since 2016, I am doing research on preparation and quality control of 99mTc radiopharmaceuticals. The research being carried out are 99mTc-tetrofosmin and 99mTc-macro-aggregate albumin for the diagnosis of cardiac and pulmonary function respectively.
Since 2019 until now, I am recently also started working on radiolabelling of cromic acid with 32P for radiosynovectomi agent.